TCON Stock, TRACON Pharmaceuticals Inc. Information
Stock Information
Get TCON Alerts
News, Short Squeeze, Breakout and More Instantly...
About TRACON Pharmaceuticals Inc.
TRACON Pharmaceuticals Inc is a biopharmaceutical company focused on the development and commercialization of novel targeted therapeutics for cancer and utilizing its cost efficient, contract research organization (CRO) independent product development platform to partner with ex-U.S. companies to develop and commercialize innovative products in the United States. The company's drug candidate includes Envafolimab, TRC102, TRC253, TJ4309, Bispecific Antibodies.